fda statement bpc-157 compounding safety risks BIG NEWS FOR BPC 157 Today, the FDA's Pharmacy Advisory Committee voted 8 to 6 to recommend adding BPC 157 to the list of substances that may be eligible for pharmacy The experts will take votes

The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. Survey: Half of Peptide Users Aren't Aware of FDA Approval Status The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline

SKU: 78993072415 · From trustt.digital